COMPARATIVE STUDIES ON UROKINASE AND PLASMINOGEN ACTIVATOR FROM CULTURED PANCREATIC-CARCINOMA

被引:7
|
作者
WU, MC
YUNIS, AA
机构
[1] UNIV MIAMI, SCH MED, DEPT BIOCHEM, MIAMI, FL 33136 USA
[2] HOWARD HUGHES MED INST, MIAMI, FL 33101 USA
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY | 1979年 / 10卷 / 12期
关键词
D O I
10.1016/0020-711X(79)90080-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1001 / 1006
页数:6
相关论文
共 50 条
  • [31] The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
    Stephens, RW
    Brünner, N
    Jänicke, F
    Schmitt, M
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 99 - 111
  • [32] NMR-STUDIES ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    NOWAK, UK
    SMITH, RAG
    DOBSON, CM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 159 - 159
  • [33] REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR PRODUCTION BY CULTURED HUMAN CYTOTROPHOBLASTS
    QUEENAN, JT
    KAO, LC
    ARBOLEDA, CE
    ULLOAAGUIRRE, A
    GOLOS, TG
    CINES, DB
    STRAUSS, JF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (23) : 10903 - 10906
  • [34] Inhibition of urokinase plasminogen activator expression by deferoxamine in cultured human prostate cancer cells
    Ornstein, DL
    Zacharki, LR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2263 - P2263
  • [35] Fibronectinase activity in cultured human trophoblasts is mediated by urokinase-type plasminogen activator
    MonzonBordonaba, F
    Wang, CL
    Feinberg, RF
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (01) : 58 - 65
  • [36] PEAKS IN PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 CONCENTRATION MAY EXPLAIN THROMBOTIC EVENTS IN CASES OF PANCREATIC-CARCINOMA
    ANDRENSANDBERG, A
    LECANDER, I
    MARTINSSON, G
    ASTEDT, B
    CANCER, 1992, 69 (12) : 2884 - 2887
  • [37] Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma
    Itoh, T
    Hayashi, Y
    Kanamaru, T
    Morita, Y
    Suzuki, S
    Wang, WP
    Zhou, L
    Rui, JA
    Yamamoto, M
    Kuroda, Y
    Itoh, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (04) : 422 - 430
  • [38] Low levels of urokinase plasminogen activator components in basal cell carcinoma of the skin
    Maguire, T
    Chin, D
    Soutar, D
    Duffy, MJ
    INTERNATIONAL JOURNAL OF CANCER, 2000, 85 (04) : 457 - 459
  • [39] Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer
    Asuthkar, Swapna
    Stepanova, Victoria
    Lebedeva, Tatiana
    Holterman, AiXuan L.
    Estes, Norman
    Cines, Douglas B.
    Rao, Jasti S.
    Gondi, Christopher S.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (17) : 2620 - 2632
  • [40] Targeting the Urokinase Plasminogen Activator Pathway in Combination With Chemotherapy Inhibits Pancreatic Cancer Progression
    Hosen, S. M. Z.
    Xu, Z.
    Perera, C.
    Mekapogu, A. R.
    Pang, T. C. Y.
    Goldstein, D.
    Pirola, R. C.
    Wilson, J. S.
    Buckley, B. J.
    Ranson, M.
    Apte, M. V.
    PANCREAS, 2021, 50 (07) : 1065 - 1065